Femoston, a hormone replacement therapy (HRT)

Drug carton for 'Femoston' an estradiol and dydrogesterone combined hormone replacement therapy (HRT) taken as tablets, made by Mylan Products Ltd, United Kingdom, manufactured in the Netherlands, 2022.

Femoston is a hormone replacement therapy (HRT) taken as tablets, for managing the symptoms of menopause and reducing the risk of osteoporosis. It was made c.2022 by Mylan Products, a pharmaceutical company specialising in producing generic (equivalent to a brand) medicines. Femoston contains two types of hormones, an oestrogen and a progestogen (Estradiol/ Dydrogesterone). One tablet would be taken daily. This pack would have contained 84 tablets to last 3 months.

Oestrogen (in this case in the form of estradiol) can be given as a supplement to replace the falling levels in the body and help reduce the symptoms of the menopause. A progestogen (in this case in the form of dydrogesterone) is given to reduce the risk of cancer of the womb lining. This is known as combined HRT.